HCM
MED icon

Hollencrest Capital Management’s Medifast MED Stock Holding History

Hollencrest Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,000
Closed -$67.2K – 1127
2023
Q4 		$67.2K Hold
1,000
– – 0.01% 436
2023
Q3 		$74.8K Hold
1,000
– – 0.01% 408
2023
Q2 		$92.2K Buy
1,000
+800
+400% +$71.2K 0.01% 392
2023
Q1 		$20.7K Sell
200
-600
-75% -$66.5K ﹤0.01% 639
2022
Q4 		$92.3K Buy
+800
New +$93.2K 0.01% 344
2020
Q2 		– Sell
-4,000
Closed -$250K – 313
2020
Q1 		$250K Buy
4,000
+2,000
+100% +$182K 0.04% 216
2019
Q4 		$219K Buy
+2,000
New +$194K 0.02% 281

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Hollencrest Capital Management's MED Position: Q1 2024 in Review

Hollencrest Capital Management sold out of Medifast (MED) in Q1 2024, closing a stake of 1,000 shares — an estimated $67.2K sold.

Hollencrest Capital Management first reported a position in MED in Q4 2019 and held it in 7 quarters. The position peaked at $250K in Q1 2020. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

  • Hollencrest Capital Management reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
  • Hollencrest Capital Management sold 1,000 Medifast shares in Q1 2024, an estimated $67.2K.
  • Hollencrest Capital Management first reported a position in Medifast in Q4 2019 and held it in 7 quarters.
  • Hollencrest Capital Management's Medifast position peaked at $250K in Q1 2020.
  • 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Hollencrest Capital Management's 13F filing for Q1 2024, filed 1 May 2024.